Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Safety monitoring and information (122)
- Compliance and enforcement (32)
- Import and export (28)
- Shortages and supply disruptions (17)
- Sunscreens (7)
- Advertising (6)
- COVID-19 (5)
- Labelling and packaging (4)
- Weight loss products (4)
- Breast implant hub (3)
- Manufacturing (3)
- Legislation (2)
- Metal-on-metal hip replacement implants hub (1)
Type of content
Search
483 result(s) found, displaying 426 to 450
-
Safety alertsDo not use So Hard for Men tablets, Shaguar tablets, and Pulse8 for Women capsules as they contain undeclared tadalafil and are not approved. Consult your doctor if you have concerns.
-
Market actionsWeight loss drug Sibutramine (Reductil) withdrawn in Australia due to heart risks.
-
Safety alertsWe are analysing the safety of the Panvax H1N1 vaccine following reports of febrile convulsions in children.
-
Safety alertsWe are investigating febrile reactions in young children following the 2010 flu vaccine and have paused its use for kids under 5 in Western Australia.
-
Safety alerts
-
Market actionsPanvax Junior is being recalled because of a drop in potency, and all available stocks are being removed.
-
Safety alerts
-
Safety alertsConsumers are advised to stop using Hydroxycut products due to serious adverse reactions, including liver toxicity. We highlight differences between US and Australian formulations and recommend caution. Consult your doctor if concerned.
-
Safety alertsGardasil is a vaccine that protects young women from the strains of human papillomavirus (HPV) that cause 70% of cervical cancers.
-
Safety alertsStop using Viagra (sildenafil) 100mg tablets due to counterfeit concerns. Return them to your pharmacy and consult your doctor if you have any concerns.
-
Safety alertsRotavirus vaccines Rotarix and RotaTeq still recommended despite pig virus DNA fragments found.
-
Safety alertsWe are investigating adverse reactions to the 2010 flu vaccine in young children in Western Australia and have paused its use for kids under 5.
-
-
Safety alertsConsumers are advised to stop using Hydroxycut products due to reports of serious adverse reactions, including liver toxicity, and to consult their doctor if they have any concerns.
-
Safety alertsBe aware that Hydroxycut products purchased via the internet may be sourced from the US and may contain ingredients which are not permitted in low-risk medicines in Australia
-
Safety alertsWeight loss drug Sibutramine (Reductil) under safety review for cardiovascular risks.
-
Safety alertsWe are advising that there are supply issues with Physeptone (methadone) tablets due to quality control problems.
-
Safety alertsApproval has been granted for the Panvax H1N1 vaccine in children starting at 6 months, with Panvax H1N1 Junior for ages 6 months to 3 years.
-
Safety alerts
-
-
Safety alertsGinkgo biloba products with high quercetin and rutin levels have been identified. Quality standards are being reviewed.
-
Safety alertsPanvax H1N1 influenza vaccine has been approved for use in adults and children over 10 years old, with additional data needed for younger children.
-
Safety alertsAdvise to exercise caution when using Australian Hydroxycut products
-
Market actionsChuan Xiong Cha Tiao Wan pills have been recalled due to the presence of aristolochic acids, which can cause severe kidney damage and urinary tract cancer. Stop using them immediately and consult your doctor for advice.
-
Market actions